Skip to main content
Log in

Hepatocellular Carcinoma inAutoimmune Hepatitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

To determine if hepatocellular carcinoma can develop in autoimmune hepatitis in the absence of viral infection and to assess its frequency, liver tissue removed at hepatectomy was tested for HBV DNA and HCV RNA in one patient and the frequency of hepatocellular carcinoma was determined in 212 other uniformly followed individuals. The liver tissue from the propositus was uninfected and only one patient (0.5%) in the cohort undergoing routine follow-up developed malignancy during 1732 patient-years of observation. Only one of 88 patients with cirrhosis (1%) developed hepatocellular carcinoma during 1002 patient-years of observation after cirrhosis (mean, 123 ± 9 months) and of the 65 patients with histological cirrhosis for at least five years, only one developed carcinoma during 162 ± 8 months (incidence, 1 per 965 patient-years). We conclude that hepatocellular carcinoma can develop in autoimmune hepatitis in the absence of viral infection. Its occurrence is rare and only in long-standing cirrhosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J, Powell J: Cancer incidence in five continents. IARC Scientific Publication, No. 120. Lyon, International Agency for Research on Cancer, 1992

    Google Scholar 

  2. Harnois DM, Gores GJ, Ludwig J, Steers JL, LaRusso NF, Wiesner RH: Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? J Hepatol 27:512-516, 1997

    Google Scholar 

  3. Turissini SB, Kaplan MM: Hepatocellular carcinoma in primary biliary cirrhosis. Am J Gastroenterol 92:676-678, 1997

    Google Scholar 

  4. Jones DEJ, Metcalf JV, Collier JD, Bassendine MF, James OFW: Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcome. Hepatology 26:1138-1142, 1997

    Google Scholar 

  5. Carr BI, Flickinger JC, Lotze MT: Hepatobiliary cancers. In Cancer Principles and Practice of Oncology, 5th ed. VT De-Vita, S Hellman, SA Rosenberg (eds). New York, Lippincott-Raven, 1997, p 1089

    Google Scholar 

  6. Di Bisceglie AM, Carithers RL Jr, Gores GJ: Hepatocellular carcinoma. Hepatology 28:1161-1164, 1998

    Google Scholar 

  7. Read AE, Sherlock S, Harrison CV: Active “juvenile” cirrhosis considered as part of a systemic disease and the effect of corticosteroid therapy. Gut 4:378-393, 1963

    Google Scholar 

  8. Joske RA, Laurence BH, Matz LR: Familial active chronic hepatitis with hepatocellular carcinoma. Gastroenterology 62:441-444, 1972

    Google Scholar 

  9. Burroughs AK, Bassendine MF, Thomas HC, Sherlock S: Primary liver cell cancer in autoimmune chronic liver disease. Br Med J 282:273, 1981

    Google Scholar 

  10. Jakobovits AW, Gibson PR, Dudley FJ: Primary liver cell carcinoma complicating autoimmune chronic active hepatitis. Dig Dis Sci 25:694-699, 1981

    Google Scholar 

  11. Bjarnason I, Magnusson B, Bjornsson S: Idiopathic chronic active hepatitis and hepatic cell carcinoma. Acta Med Scand 211:225, 1982

    Google Scholar 

  12. Satake Y, Takada K, Ikeda K, Shiosaka T, Fujita S, Kobayashi Y: A case of primary liver cell cancer complicating lupoid hepatitis. Jpn J Med 27:83-86, 1988

    Google Scholar 

  13. Wang KK, Czaja AJ: Hepatocellular cancer in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology 8:1679-1683, 1988

    Google Scholar 

  14. Thung SN, Bach N, Fasy T, Jordan D, Schaffner F: Hepatocellular carcinoma associated with autoimmune chronic active hepatitis. Mount Sinai J Med 57:165-168, 1990

    Google Scholar 

  15. Yousuf M, Kiyosawa K, Sodeyama T, Yoda H, Nakano Y, Furuta S: Development of hepatocellular carcinoma in a man with autoimmune chronic active hepatitis. J Gastroenterol Hepatol 7:66-69, 1992

    Google Scholar 

  16. Ryder S, Koskinas J, Rizzi PM, McFarlane IG, Portmann BC, Naoumov NV, Williams R: Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus. Hepatology 22:718-722, 1995

    Google Scholar 

  17. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, Czaja AJ, Desmet V, Edleston ALWF, Gerber MA, Hoofnagle JH, Kakumu S, MacSween RNM, Maddrey WC, Manns MP, Meyer zum Buschenfelde K-H, Mieli-Vergani G, Portmann BC, Reed WD, Schalm SW, Scheuer PJ, Toda G, Tsuji T, Tygstrup N, Vergani D, Zeniya M: Meeting report. International Autoimmune Hepatitis Group. Hepatology 18:998-1005, 1993

    Google Scholar 

  18. Czaja AJ, Magrin S, Fabiano C, Fiorentino G, Diquattro O, Craxi A, Pagliaro L: Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis. Dig Dis Sci 40:33-40, 1995

    Google Scholar 

  19. Czaja AJ, Carpenter HA: Sensitivity, specificity and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 105:1824-1832, 1993

    Google Scholar 

  20. Czaja AJ: Drug therapy in the management of type 1 autoimmune hepatitis. Drugs 57:49-68, 1999

    Google Scholar 

  21. Czaja AJ, Manns MP: The validity and importance of subtypes of autoimmune hepatitis: A point of view. Amer J Gastroenterol 90:1206-1211, 1995

    Google Scholar 

  22. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 24:1068-1073, 1996

    Google Scholar 

  23. Czaja AJ, Cassani F, Cataleta M, Valentini P, Bianchi FB: Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis. Dig Dis Sci 42:1688-1696, 1997

    Google Scholar 

  24. Czaja AJ, Manns MP, Homburger HA: Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 103:1290-1295, 1992

    Google Scholar 

  25. Roberts SK, Therneau T, Czaja AJ: Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 110:848-857, 1996

    Google Scholar 

  26. Liang TJ, Jeffers LJ, Reddy R, Medina MD, Parker IT, Cheinquer H, Idrovo V, Rabassa A, Schiff ER: Viral pathogenesis of hepatocellular carcinoma in the United States. Hepatology 18:1326-1333, 1993

    Google Scholar 

  27. Regan LS: Screening for hepatocellular carcinoma in high-risk individuals. A clinical review. Arch Intern Med 149:1741-1744, 1989

    Google Scholar 

  28. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, Donato MF, Piva A, Di Carlo V, Dioguardi N: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 325:675-680, 1991

    Google Scholar 

  29. Trevisani F, D'Intino PE, Bernardi M: Prospective screening for hepatocellular carcinoma: a debated issue. J Hepatol 22:708-709, 1995

    Google Scholar 

  30. Collier J, Sherman M: Screening for hepatocellular cancer. Hepatology 27:273-278, 1998

    Google Scholar 

  31. Colombo M: Screening for hepatocellular carcinoma. Digestion 59(suppl 2):70-71, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, S.Z., Nagorney, D.M. & Czaja, A.J. Hepatocellular Carcinoma inAutoimmune Hepatitis. Dig Dis Sci 45, 1944–1948 (2000). https://doi.org/10.1023/A:1005638500236

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005638500236

Navigation